A bill to end the record-breaking U.S. government shutdown is headed to President Donald Trump’s desk after more than 42…
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing…